18F-FDG PET imaging of myocardial inflammation and viability following experimental infarction and anti-inflammatory treatment with compound MCC950

¹⁸F-FDG PET imaging of myocardial inflammation and viability following experimental infarction and anti-inflammatory treatment with compound MCC950

J Nucl Cardiol. 2021 Oct;28(5):2358-2360. doi: 10.1007/s12350-020-02104-5. Epub 2020 Apr 24.

Jeremy Jong¹, René R Sevag Packard^{2

3

4}

¹ Division of Cardiology, Department of Medicine, David Geffen School of Medicine, University of California, 10833 Le Conte Ave., CHS Building Room 17-054A, Los Angeles, CA, 90095, USA.
² Division of Cardiology, Department of Medicine, David Geffen School of Medicine, University of California, 10833 Le Conte Ave., CHS Building Room 17-054A, Los Angeles, CA, 90095, USA. rpackard@mednet.ucla.edu.
³ Ronald Reagan UCLA Medical Center, Los Angeles, CA, USA. rpackard@mednet.ucla.edu.
⁴ Veterans Affairs West Los Angeles Medical Center, Los Angeles, CA, USA. rpackard@mednet.ucla.edu.

No abstract available

Anti-Inflammatory Agents
Furans
Indenes
Radiopharmaceuticals
Sulfonamides
Fluorodeoxyglucose F18
N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide